BioAtla Garners $30,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    11011 Torreyana Road San Diego, CA 92121 USA
  • Company Description
    BioAtla uses deep expertise in protein and antibody engineering and proprietary technologies to solve critical protein development challenges and produce novel, IP-protectable products for our partners and our own product portfolio.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The proceeds will be used to accelerate the development of the company’s CAB antibody drug pipeline.
  • M&A Terms
  • Venture Investor

Trending on Xconomy